PharmGen Science Inc (004720) — Cash Flow Reinvestment Rate
PharmGen Science Inc (004720) has a Cash Flow Reinvestment Rate of 0.78x as of September 2025, reinvesting ₩1.48 Billion (capex ₩799.96 Million plus investments ₩-680.92 Million) from operating cash flow of ₩1.91 Billion. See PharmGen Science Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
PharmGen Science Inc Cash Flow Reinvestment Rate (2011–2024)
Historical reinvestment intensity for PharmGen Science Inc across 10 annual periods. For the full cash flow conversion analysis, see 004720 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for PharmGen Science Inc (2011–2024)
Year-by-year capital reinvestment analysis for PharmGen Science Inc. See 004720 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.54x | ₩3.67 Billion | ₩2.38 Billion | ₩2.78 Billion | ▲ +74.9% |
| 2023 | 0.88x | ₩4.79 Billion | ₩5.44 Billion | ₩3.29 Billion | ▼ -78.7% |
| 2021 | 4.14x | ₩32.25 Billion | ₩7.78 Billion | ₩30.75 Billion | ▲ +126.7% |
| 2020 | 1.83x | ₩4.89 Billion | ₩2.68 Billion | ₩4.34 Billion | ▼ -55.8% |
| 2019 | 4.14x | ₩10.44 Billion | ₩2.52 Billion | ₩6.16 Billion | ▲ +84.6% |
| 2018 | 2.24x | ₩9.45 Billion | ₩4.22 Billion | ₩892.34 Million | ▲ +161.2% |
| 2017 | 0.86x | ₩1.58 Billion | ₩1.84 Billion | ₩1.54 Billion | ▼ -65.4% |
| 2016 | 2.48x | ₩19.26 Billion | ₩7.75 Billion | ₩3.43 Billion | ▲ +123.6% |
| 2015 | 1.11x | ₩4.02 Billion | ₩3.62 Billion | ₩771.87 Million | ▲ +400.3% |
| 2011 | 0.22x | ₩642.43 Million | ₩2.89 Billion | ₩642.43 Million | — |